Abl Bio, Inc.
Clinical trials sponsored by Abl Bio, Inc., explained in plain language.
-
New cancer drug combo seeks to shrink advanced tumors
Disease control Recruiting nowThis early-stage trial is testing the safety and effectiveness of a new drug called ABL103 when combined with an existing immunotherapy (pembrolizumab), with or without chemotherapy. It's for adults with advanced or spreading solid tumors that have continued to grow despite stand…
Phase: PHASE1, PHASE2 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New Two-Target cancer drug enters first human trials
Disease control Recruiting nowThis is the first human study of an experimental drug called ABL103 for people with advanced solid tumors that have progressed despite standard treatments. The study aims to find the safest dose and see if the drug shows early signs of fighting cancer. It will enroll 96 adults wh…
Phase: PHASE1 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC